sisätautioppi
Yhteystiedot
Henkilöt
Julkaisut
- Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry (2021)
- Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018)
- Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial (2011)
- Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure (2022)
- Risk Stratification by Self-Measured Home Blood Pressure across Categories of Conventional Blood Pressure – A Participant-Level Meta-Analysis (2014)
- Ristiriitaiset verenpainetaudin muodot : valkotakkihypertensio ja piilevä hypertensio (2023)
- Rituksimabi turvallinen ja tehokas munuaiskerästulehduksen hoidossa (2017)
- Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction From the COMPASS Trial (2019)
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial (2018)
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (2017)





